Evommune, Inc. (EVMN)
12.45
-0.21
(-1.66%)
USD |
NYSE |
Sep 01, 12:58
Evommune Net Income (TTM) : -94.67M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -94.67M |
| March 31, 2026 | -75.99M |
| December 31, 2025 | -68.87M |
| Date | Value |
|---|---|
| September 30, 2025 | -56.51M |
| June 30, 2025 | -71.42M |
| March 31, 2025 | -60.64M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| MapLight Therapeutics, Inc. | -229.83M |
| Mineralys Therapeutics, Inc. | -349.58M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |